Compound 680
Identifiers
- Canonical SMILES:
CN1c2ncnn2[C@H](C2=C1c1c(F)cccc1O[C@@H]2c1ccc(Br)cc1)c1ccc(Br)cc1
- InChi:
InChI=1S/C25H17Br2FN4O/c1-31-23-20-18(28)3-2-4-19(20)33-24(15-7-11-17(27)12-8-15)21(23)22(32-25(31)29-13-30-32)14-5-9-16(26)10-6-14/h2-13,22,24H,1H3/t22-,24+/m0/s1
- InChiKey:
UZZAUBNWYYZQJH-LADGPHEKSA-N
External links
44549763 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.76 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 565.98 g/mol | |||
HBA | 5 | |||
HBD | 0 | |||
HBA + HBD | 5 | |||
AlogP | 6.65 | |||
TPSA | 43.18 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4414 | BMS-394136 | DB12067 | |
0.3633 | GDC-0927 | DB14934 | |
0.3600 | Parsaclisib | DB14867 | |
0.3450 | Posaconazole | DB01263 | |
0.3357 | LY-2881835 | DB15046 | |
0.3342 | Naldemedine | DB11691 | |
0.3304 | (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium | DB02673 | |
0.3257 | E-2012 | DB05171 | |
0.3242 | Rocaglamide | DB15495 | |
0.3235 | Galicaftor | DB14894 | |
0.3230 | Monastrol | DB04331 | |
0.3218 | Desvancosaminyl vancomycin | DB04529 | |
0.3199 | MK-1775 | DB11740 | |
0.3194 | Vancomycin | DB00512 | |
0.3191 | Iclaprim | DB06358 |